Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Total 13F shares
-
41,355
-
Share change
-
0
-
Total reported value
-
$70,304
-
Price per share
-
$1.70
-
Number of holders
-
1
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q4 2023
As of 31 Dec 2023 HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) had 1 institutional shareholder that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 41,355 shares of stock of the company.
Largest 10 holders included Rubric Capital Management LP, VANGUARD GROUP INC, BlackRock Inc., Velan Capital Investment Management LP, FRANKLIN RESOURCES INC, Clearline Capital LP, ORBIMED ADVISORS LLC, Tejara Capital Ltd, PALISADE CAPITAL MANAGEMENT, LP, and ADAGE CAPITAL PARTNERS GP, L.L.C..
This table shows 149 institutional shareholders of the security as of 31 Dec 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.